2,111
Views
3
CrossRef citations to date
0
Altmetric
Original Articles: Clinical Oncology

The risk of recurrence in surgically treated head and neck squamous cell carcinomas: a conditional probability approach

ORCID Icon, , ORCID Icon, , , , , , , , , , , , , , , , ORCID Icon, , ORCID Icon, , , , , & ORCID Icon show all
Pages 942-947 | Received 21 Sep 2020, Accepted 29 Apr 2021, Published online: 20 May 2021

References

  • Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953.
  • Johnson DE, Burtness B, Leemans CR, et al. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92.
  • Gatta G, Botta L, Sánchez MJ, et al. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: the EUROCARE-5 population-based study. Eur J Cancer. 2015;51:2130–2143.
  • Hodler J, Kubik-Huch RA, von Schulthess GK, et al., eds. Diseases of the brain, head and neck, spine 2020–2023: diagnostic imaging. Cham, CH: Springer;2020.
  • Hoffman HT, Karnell LH, Funk GF, et al. The national cancer database report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124:951–962.
  • Roman BR, Goldenberg D, Givi B. Education Committee of American Head and Neck Society (AHNS), AHNS series–do you know your guidelines? Guideline recommended follow-up and surveillance of head and neck cancer survivors. Head Neck. 2016;38:168–174.
  • Kalbfleisch JD, Prentice RL, eds. The statistical analysis of failure time data. Hoboken, USA: John Wiley & Sons;2002.
  • Prasad V, Bila U. The role of censoring on progression free survival: oncologist discretion advised. Eur J Cancer. 2015;51:2269–2271.
  • Aalen O, Johansen S. An empirical transition matrix for non‐homogeneous Markov chains based on censored observations. Scand J Stat 1987. 1978;5:141–150.
  • Deganello A, Franchi A, Sardi I, et al. Genetic alterations between primary head and neck squamous cell carcinoma and recurrence after radiotherapy: recurrence, genetically related cancer, or second primary? Cancer. 2010;116:1291–1297.
  • Boscolo-Rizzo P, Rampazzo E, Perissinotto E, et al. Telomere shortening in mucosa surrounding the tumor: Biosensor of field cancerization and prognostic marker of mucosal failure in head and neck squamous cell carcinoma. Oral Oncol. 2015;51:500–507.
  • McLarnon C, Kulloo P, Mehanna H, et al. Quality-of-life considerations in treatment of unresectable, recurrent head and neck cancer. Expert Rev Anticancer Ther. 2010;10:345–352.
  • Chen L, Cohen EE. Surrogate endpoints in head and neck cancer. Lancet Oncol. 2009;10(4):309–310.
  • Brennan KE, Hall SF, Owen TE, et al. Variation in routine follow-up care after curative treatment for head-and-neck cancer: a population-based study in Ontario. Curr Oncol. 2018;25(2):e120–31–131.
  • Du E, Mazul AL, Farquhar D, et al. Long-term survival in head and neck cancer: Impact of site, stage, smoking, and Human Papillomavirus status. Laryngoscope. 2019;129:2506–2513.
  • Fuller CD, Wang SJ, Thomas CR, et al. Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998. Cancer. 2007;109(7):1331–1343.
  • Wang SJ, Wissel AR, Ord CB, et al. Individualized estimation of conditional survival for head and neck cancer patients. Otolaryngol Head Neck Surg. 2011;145:71–73.
  • Min SK, Choi SW, Ha J, et al. Conditional relative survival of oral cavity cancer: based on Korean Central Cancer Registry. Oral Oncol. 2017;72:73–79.
  • Mathew A, Pandey M, Murthy NS. Survival analysis: caveats and pitfalls. Eur J Surg Oncol. 1999;25:321–329.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.